As of March 2024 Cara Therapeutics has a market cap of $49.59 Million. This makes Cara Therapeutics the world's 7685th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $49.59 M | 22.52% |
2023 | $40.47 M | -92.99% |
2022 | $0.57 B | -11.37% |
2021 | $0.65 B | -13.64% |
2020 | $0.75 B | 0.17% |
2019 | $0.75 B | 46.4% |
2018 | $0.51 B | 28.81% |
2017 | $0.39 B | 57.47% |
2016 | $0.25 B | -44.84% |
2015 | $0.45 B | 102.13% |
2014 | $0.22 B |
On Mar 18th, 2024 the market cap of Cara Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $377.75 B | 761,580.47% | ๐บ๐ธ USA |
Pfizer PFE | $156.96 B | 316,393.41% | ๐บ๐ธ USA |
Trevena TRVN | $10.07 M | -79.68% | ๐บ๐ธ USA |
Recro Pharma
REPH | $0.12 B | 148.48% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | $0.45 B | 825.35% | ๐บ๐ธ USA |
Acorda Therapeutics
ACOR | $16.76 M | -66.19% | ๐บ๐ธ USA |
AcelRx Pharmaceuticals
ACRX | $14.57 M | -70.60% | ๐บ๐ธ USA |